SIRPA and infection: Moreover, CD172a+/CD163−/MHC-II+ and CD172a−/CD163−/MHC-II+ cells exhibit strong migration and antigen-presenting capabilities [10], which can be credited to the increased influx of these cells into the lungs during the course of infection.